In the present study, we investigated the effects of a chronic oral treatment with 10 and 20 mg/Kg/Day of anatabine on the pathological deposition of Aβ, neuroinflammation and behavior in a transgenic mouse model of AD (Tg PS1/APPswe). The gene discussed is PSEN1; the disease is Alzheimer disease.